Clinical Trials on Cancer, Hepatocellular in Russian Federation
Total 847 results
-
Eisai LimitedCompletedMetastatic Breast CancerUnited Kingdom, Bulgaria, Russian Federation
-
AB ScienceCompletedMetastatic Castrate Resistant Prostate CancerItaly, Russian Federation, India, Canada, France, Malaysia
-
BayerCompletedCarcinoma, HepatocellularJapan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
-
Bristol-Myers SquibbTerminatedCancer, HepatocellularChina, United States, Germany, Australia, Italy, Austria, Belgium, Czechia, France, Hong Kong, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Taiwan, Canada
-
Eli Lilly and CompanyCompletedBreast CancerSpain, Italy, Russian Federation, Germany
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompletedHepatocellular CarcinomaUnited States, Spain, France, Italy, Japan, Russian Federation, United Kingdom
-
AB ScienceCompletedLocally Advanced or Metastatic Pancreatic CancerFrance, Belgium, Greece, India, Russian Federation, Slovakia, Tunisia, Ukraine
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
Population Health Research InstituteRecruitingHeart Failure | Breast CancerCanada, Brazil, Russian Federation
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
Adherex Technologies, Inc.UnknownMetastatic Breast CancerUnited States, Russian Federation
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Novartis PharmaceuticalsRecruiting
-
AB ScienceCompletedOvarian CancerFrance, United Kingdom, Ukraine, Algeria, Russian Federation, Spain
-
AstraZenecaCompletedLINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)Local Advanced or Metastatic Postmenopausal Breast CancerRussian Federation
-
AstraZenecaCompletedAdvanced Breast CancerRussian Federation, Ukraine, Czech Republic
-
AstraZenecaRecruitingNon-small-cell Lung CancerRussian Federation
-
Grünenthal GmbHTerminatedPain | Cancer | Chronic PainBulgaria, Hungary, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia
-
Mabscale, LLCRecruitingNon-Small Cell Lung CancerRussian Federation
-
Eisai Inc.CompletedThyroid CancerUnited States, France, Ukraine, Peru, Russian Federation, Argentina
-
Poniard PharmaceuticalsUnknown
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
Ascenta TherapeuticsCompletedNon-small Cell Lung CancerRussian Federation, United States, Ukraine
-
TularikTerminatedHepatocellular CarcinomaUnited States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular Carcinoma | Liver CancerUnited States, Canada, Germany, France, Russian Federation, Argentina, Australia, Austria, Belgium, Brazil, Chile, Colombia, Hong Kong, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Puerto Rico, Romania, Sing... and more
-
BiocadRecruitingCervical CancerGeorgia, Russian Federation, China, Turkey
-
Hoffmann-La RocheActive, not recruitingUnresectable Hepatocellular CarcinomaCanada, Belgium, Korea, Republic of, Brazil, China, Croatia, Spain, Taiwan, Turkey, Italy, India, United Kingdom, Thailand, Costa Rica, Japan, France, Germany, Austria, Israel, Malaysia, Philippines, Estonia, Russian Federation, Greece, Bulgari... and more
-
AbbottTerminatedLiver Diseases | Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Hepatocellular Carcinoma Non-resectable | Hepatocellular Carcinoma...United States, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Norway, Puerto... and more
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
UCB PharmaCompletedCarcinoma | Non-Squamous Non-Small-Cell Lung CancerPoland, Russian Federation, Hungary
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
GlaxoSmithKlineCompletedLung Cancer, Small CellBulgaria, Hungary, Russian Federation, Netherlands, Ukraine, United Kingdom
-
Halozyme TherapeuticsCompletedStage IV Pancreatic CancerUnited States, Russian Federation
-
FeRxTerminatedCarcinoma, HepatocellularUnited States, Austria, Thailand, Germany, Ukraine, United Kingdom, Hong Kong, Russian Federation
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma (HCC)Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Canada, Russian Federation, United States, Argentina, United Kingdom
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedCarcinoma, HepatocellularPuerto Rico, United States, Germany, Ukraine, Russian Federation, Poland, Romania
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
AstraZenecaRUSSCO (Russian Society of Clinical Oncology)CompletedOvarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in RussiaRussian Federation
-
Novartis PharmaceuticalsTerminatedCancerCzechia, Poland, Russian Federation, United Kingdom, Israel
-
Ascenta TherapeuticsCompletedSmall Cell Lung CancerUnited States, Russian Federation, Ukraine
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Maxygen Holdings Ltd.Parexel; Maxygen ApS; Maxygen, Inc.UnknownBreast Cancer | Chemotherapy-Induced NeutropeniaPoland, Romania, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
BIND TherapeuticsCompletedNon-small Cell Lung CancerUnited States, Russian Federation
-
AstraZenecaRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingCancer | Lung CancerKorea, Republic of, Spain, Germany, Japan, Taiwan, China, Italy, United States, Belgium, Russian Federation, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Eli Lilly and CompanyCompletedFallopian Tube Neoplasms | Ovarian Cancer | Peritoneal NeoplasmSpain, Poland, Belgium, Russian Federation, Germany